AU636488C - Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases - Google Patents

Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases

Info

Publication number
AU636488C
AU636488C AU77133/91A AU7713391A AU636488C AU 636488 C AU636488 C AU 636488C AU 77133/91 A AU77133/91 A AU 77133/91A AU 7713391 A AU7713391 A AU 7713391A AU 636488 C AU636488 C AU 636488C
Authority
AU
Australia
Prior art keywords
euronal
naphthylethyl
tetrahydropyridine
trifluoromethylphenyl
cerebral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU77133/91A
Other versions
AU7713391A (en
AU636488B2 (en
Inventor
Francois Xavier Coude
Jacqueline Fournier
Umberto Guzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9006399A external-priority patent/FR2662355B1/en
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of AU7713391A publication Critical patent/AU7713391A/en
Application granted granted Critical
Publication of AU636488B2 publication Critical patent/AU636488B2/en
Publication of AU636488C publication Critical patent/AU636488C/en
Assigned to SANOFI-SYNTHELABO reassignment SANOFI-SYNTHELABO Request to Amend Deed and Register Assignors: SANOFI
Assigned to SANOFI-AVENTIS reassignment SANOFI-AVENTIS Request to Amend Deed and Register Assignors: SANOFI-SYNTHELABO
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU77133/91A 1990-05-22 1991-05-20 Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases Expired AU636488C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006399 1990-05-22
FR9006399A FR2662355B1 (en) 1990-05-22 1990-05-22 USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.

Publications (3)

Publication Number Publication Date
AU7713391A AU7713391A (en) 1991-11-28
AU636488B2 AU636488B2 (en) 1993-04-29
AU636488C true AU636488C (en) 1993-10-14

Family

ID=

Similar Documents

Publication Publication Date Title
AR243759A1 (en) Improvements in the treatment of a tooth
IL105683A0 (en) Ophthalmologic cannula
EP0333344A3 (en) Corneal implants and manufacture and use thereof
EP0661024A3 (en) Disposable filter for dental handpiece.
EP0331620A3 (en) Agent for the treatment of parkinson's disease
HUP9802945A3 (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
AU1674492A (en) Alzheimer's disease treatment with tacrine metabolites
ZA909855B (en) 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
ZA902566B (en) 2-substituted n,n'-ditrimethoxybenzoyl piperazines,a preparation process of the samde and therapeutic compositions containing them
EP0511546A3 (en) Investment material and mold for dental use and burnout thereof
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
AU636488C (en) Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases
HU9403321D0 (en) Remedy for cataract and production thereof
AU1662092A (en) Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
EP0441736A3 (en) New 1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow
EP0644716A4 (en) Medical uses of trioxolane and diperoxide compounds.
AU3084992A (en) 1,4-dihydropyridines for use in the treatment of dermatosis
AU4807390A (en) Novel fitted dental prosthesis and process for the manufacture thereof
NZ260212A (en) 3-phenyl-1,2,5,6-tetrahydropyridine and use as a medicament
DE69011356D1 (en) 6'-Deoxy-6'-halogenoneplanosin A and its preparation.
EP0279462A3 (en) 4,4'-(perfluoroisopropylidene)dicyclohexanol, derivative thereof and process for preparing the same
GB2270313B (en) 1,3,4-Benzotriazepin-5 (4H)-one derivatives and process for the preparation thereof
GB9816517D0 (en) 2,3-distributed cyclopentanone derivatives process for producing the same and medicinal use theeof
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease